Director/PDMR Shareholding

By

Regulatory News | 11 Aug, 2020

Updated : 16:45

RNS Number : 8337V
RSA Insurance Group PLC
11 August 2020
 

RSA Insurance Group plc ("the Company")

 

Transactions in shares by Persons Discharging Managerial Responsibility ("PDMRs")

 

11 August 2020

 

On 10 August 2020, the Company received notification of the following transaction in its ordinary shares of £1.00 each ("Ordinary Shares") by a PDMR.

On 10 August 2020, William McDonnell, Group Chief Risk Officer, exercised his share option to purchase 2,142 Ordinary Shares at an exercise price of £4.20 per share following the maturity of the Company's 2016 Sharesave Plan.

The forms required under the EU Market Abuse Regulation follows.

 

1.

Details of PDMR / Person Closely Associated ("PCA")

a)

Name

William McDonnell

b)

Position / status

Group Chief Risk Officer

c)

Initial notification / amendment

Initial Notification

 

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

 

b)

Nature of the transaction

Exercise of share option to purchase 2,142 Ordinary Shares following maturity of the Company's 2016 Sharesave Plan. All the shares were retained on exercise.

 

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

GBP 4.20

2,142

 

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

2,142

GBP 4.20

e)

Date of the transaction

2020-08-10

f)

Place of the transaction

XLON London Stock Exchange

    

 

 

 

 

Enquiries to:

 

Christopher Smyth, Deputy Group Company Secretary

 

RSA Insurance Group plc

 

Tel:  +44 (0) 20 7111 7000

 

Website: www.rsagroup.com                           

--ENDS--


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFZGMRKMZGGZM

Last news